The Global Actinic Keratosis Treatment Industry, valued at a noteworthy US$5.4 billion in 2022, is on the verge of an unprecedented surge, with projections indicating a staggering US$8.0 billion by 2028. This compelling insight comes from the latest comprehensive report by Future Market Insights (FMI), a leading market research firm. The industry is poised to …